DSpace Repository

Influence OF anticancer drugs on DNA methylation in liver of female mice

Show simple item record

dc.contributor.author Hanafy, Shaden M.
dc.contributor.author Salem, Tarek A.
dc.contributor.author El-Aziz, Amal A.
dc.contributor.author EL-Fiky, Bahgat A.
dc.contributor.author Shokair, Mahmoud A.
dc.date.accessioned 2016-10-18T05:31:55Z
dc.date.available 2016-10-18T05:31:55Z
dc.date.issued 2011-06
dc.identifier.citation American Journal of Molecular Biology, 2011, 1, 62-69 en_US
dc.identifier.uri http://dx.doi.org/10.4236/ajmb.2011.12008
dc.identifier.uri http://hdl.handle.net/123456789/968
dc.description.abstract Epigenetic changes such as DNA methylation regulate gene expression in normal development. Methotrexate and Adriamycine are antineoplastic drugs that target DNA and enzymes acting on DNA. We aimed to evaluate their cytotoxic effect on cell lines and on female mice to investigate the in vivo influence of both drugs on the DNA methylation and subsequently the protein expression. The total level of DNA methylation showed a significant reduction from 62.2% to 36.7%, 36.6% as compared to control group, when using different doses of MTX and ADR. Hepatic protein pattern revealed five bands with low MW (16 - 6.1 KDa) in acute and LD50 doses. In conclusion DNA methylation is influenced by anticancer drugs in a dose - dependent manner. Some specific protein fragments may be considered as a potential markers associated with high dose of anticancer drugs. en_US
dc.language.iso en en_US
dc.publisher Scientific Research Publishing en_US
dc.subject Epigenetic en_US
dc.subject DNA Methylation en_US
dc.subject Methotrexate (MTX) and Adriamycine (ADR) en_US
dc.title Influence OF anticancer drugs on DNA methylation in liver of female mice en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account